Home

Catalyst Healthcare
Consulting

Igniting progress at the intersection of regulation, policy, and innovation

Advancing the
bottom line with
the patient in mind

Catalyst Healthcare Consulting is a dynamic, hands-on regulatory policy and regulatory affairs partner dedicated to helping clients advance innovative healthcare solutions that benefit patients.

Our team builds fit-for-purpose solutions to accelerate product development, advance policy objectives, improve the regulatory environment, understand reimbursement realities, all to help inform business decisions.  Our clients include global innovators, start-ups, state agencies, patient advocates, investors, universities, non-profits and trade associations.

Our core team

With you at every stage of development

At Catalyst, we prefer the cutting edge. Our creativity is unleashed as we work with clients across a mix of projects that support start-ups, global sponsors, patient groups, and emerging coalitions of like-minded innovators.

Our broad-reaching portfolio gives us a 360° view of the healthcare ecosystem. By thinking like patients, industry leaders, investors, and regulators, we anticipate trends and craft bold solutions to complex challenges.

Discover how Catalyst’s expertise can power your success.

Start-up support

Advancing products
and pipelines

Building industry
consensus

View capabilities

20 years of advancing partner objectives

Catalyst’s strength is the diversity and complexity of the projects we choose to accept, both at home and abroad

Our clients include

  • Industry: cell and gene therapy, pharma,
digital therapeutics, and devices
  • Trade associations
  • Patient advocacy organizations
  • Venture capital and investment firms
  • Law and public relations firms
  • State agencies
  • Academic institutions
See expanded list

Upcoming events

Advancing Pediatric Cell and Gene Therapy Clinical Trials: Scientific, Ethical, Regulatory, and Practical Considerations

April 9, 2026

Catalyst looks forward to participating in the upcoming joint FDA and ARM workshop “Advancing Pediatric Cell and Gene Therapy Clinical Trials: Scientific, Ethical, Regulatory, and Practical Considerations.” If you are attending, we would welcome the chance to connect.

Meeting on the Med 2026

April 28 – 30, 2026

Catalyst’s Nancy Myers will be attending ARM’s upcoming Meeting on the Mesa. If you are attending, reach out on LinkedIn!

Learn more